Hear from Prof. Felix JF Herth as he discusses insights from his recent study on cautery cryobiopsy in Primary Mediastinal Large B-Cell Lymphoma at the recent WCBIP. He shares perspectives on diagnostic yield and procedure time, exploring this approach within mediastinal diagnostics. #Pulmonology #cryobiopsy
Erbe Bronchoscopy’s Post
More Relevant Posts
-
Keep updated with the latest #Lymphoma news, events, support services, campaigns and ways you can get involved – including our Lymphoma Matters magazine, by signing up to our regular newsletters. Avoid missing out 👉 https://lnkd.in/e_p6MieS Together we can make sure no one has to face their lymphoma alone 💜. #LymphomaCancer #BloodCancer #LymphomaSupport #LymphomaMatters #Newsletter
-
-
Today, we presented results from a Phase 2 proof-of-concept study at the 2025 American Society of Hematology (ASH) Annual Meeting. These findings underscore the potential to enhance complete responses and durability following CD19-directed CAR-T therapy in patients with relapsed/refractory Large B-cell Lymphoma (LBCL). To learn more about these exciting developments, read the full press release here: https://bit.ly/41kpX3L #ASH24
-
-
Today we published our Q3 Report. This has been a period of progress for 4SC AG, as we continue to advance the development of our lead asset #resminostat (#Kinselby) which has been clinically proven to improve progression free survival in advanced-stage Cutaneous T-Cell Lymphoma (CTCL). You can read our Q3 Report using the links in the comments below. #CTCL #CutaneousTCellLymphoma #RareDiseases #Q3Report
-
-
💫ONCOnews💫 🌟 Columvi meets primary endpoint of overall survival in people with relapsed or refractory diffuse large B-cell lymphoma in Phase III STARGLO study 👉 Columvi, in combination with chemotherapy, demonstrated a statistically significant improvement in overall survival for people with relapsed or refractory diffuse large B-cell lymphoma 🔗 https://buff.ly/3Q0aMGr #OncEd #ONCOnews #OncoAlert
-
-
Did you know there are over 60 types of NHL? 🧬 From aggressive forms like DLBCL to indolent types, such as follicular lymphoma, each subtype tells a unique story. Knowing your subtype is essential for effective treatment! Discover more: https://bit.ly/4ezAJqt #NHL #Lymphoma #BloodCancer #StriveNHL #MedLearningGroup
-
-
✨ Free Download! Learn from expert faculty Julie Vose about key treatment considerations for younger, fit patients with mantle cell lymphoma (MCL). This slideset provides the latest insights on integrating BTK inhibitors into frontline therapy to optimize care. Download now 📩 #OncologyEducation #MCLTreatment #BTKInhibitors #CMEResources
-
World Lymphoma Awareness Day🌍 On this World Lymphoma Awareness Day, we focus on the importance of understanding and addressing lymphoma. This day highlights the need for research, early diagnosis, and improved treatments. Join us in supporting those affected and advocating for advancements in care. Every voice counts in the fight against lymphoma! 🌟 #WorldLymphomaAwarenessDay #Lymphoma #CancerAwareness #SupportAndHope #mindcrawller #research
-
-
Oncology Pharmacist @ Burjeel Medical City | ASHP Certified | SIDP Certified | Direct Patient Care | Cancer Research | Clinical Decision Making |
Molecular classification of DLBCL Solid table for lymphoma geeks such as myself https://lnkd.in/dmKmDrBE
-
-
It's here! Our newly refreshed High-grade non-Hodgkin lymphoma book is now on our website, to order or download for free 💜. It's a valuable resource if you or someone close to you is affected by this type of #Lymphoma, covering how high-grade non-Hodgkin lymphoma typically affects people, treatment and what to expect during and after treatment. Order your copy 👉 https://lnkd.in/efGQ3Er4 Download your copy 👉 https://lnkd.in/ePaYv3Zh #LymphomaCancer #BloodCancer #NonHodgkinLymphoma
-
